673 P P (Cabergoline 0.5 mg)
Pill imprint 673 P P has been identified as Cabergoline 0.5 mg.
Cabergoline is used in the treatment of hyperprolactinemia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Cabergoline 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 673 P P
- Strength:
- 0.5 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
Prolactin inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0673
- Inactive Ingredients:
- citric acid
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
More about cabergoline
Consumer resources
- Other brands: Dostinex
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
